By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


Company News
CytRx Corporation (CYTR) Announces The Completion Of Enrollment In Pivotal Global Phase 3 Trial Ahead Of Schedule 12/1/2015 7:18:36 AM
CytRx Corporation (CYTR) Release: Aldoxorubicin Continues To Demonstrate Positive Clinical Activity In Phase 2 Glioblastoma Trial 11/23/2015 7:30:05 AM
CytRx Corporation (CYTR) Reports 2015 Third Quarter Financial Results 11/3/2015 9:31:53 AM
CytRx Corporation (CYTR) To Present Additional Data From Its Phase 1b/2 Clinical Trial Combining Aldoxorubicin With Ifosfamide/Mesna At The CTOS 2015 Annual Meeting 10/28/2015 11:05:56 AM
CytRx Corporation (CYTR) Announces The Publication Of Its Positive Global Phase 2b Clinical Trial Results For Soft Tissue Sarcoma In The Peer-Reviewed JAMA Oncology 9/22/2015 10:52:43 AM
CytRx Corporation (CYTR) Announces The Presentation Of Its Phase 2b Clinical Trial Design In Small Cell Lung Cancer At The World Conference On Lung Cancer In Denver, Colorado 9/3/2015 7:24:27 AM
CytRx Corporation (CYTR) Announces Participation At FBR & Co. Second Annual Health Conference And Rodman & Renshaw 17th Annual Global Investment Conference 9/1/2015 7:34:31 AM
CytRx Corporation (CYTR) Reports 2015 Second Quarter Financial Results 8/3/2015 9:31:34 AM
CytRx Corporation (CYTR) Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/24/2015 9:46:26 AM
CytRx Corporation (CYTR) Announces Proposed Public Offering Of Common Stock 7/21/2015 11:03:59 AM